Community Inclusion in PrEP Demonstration Projects: Lessons for Scaling Up.

Pre-exposure prophylaxis (PrEP) has emerged as a new HIV prevention strategy. A series of demonstration projects were conducted to explore the use of PrEP outside of clinical trial settings. Learning from the failures in community consultation and involvement in early oral tenofovir trials, these PrEP projects attempted to better engage communities and create spaces for community involvement in the planning and roll out of these projects. We briefly describe the community engagement strategies employed by seven Bill & Melinda Gates Foundation-funded PrEP demonstration projects and the lessons these projects offer for community engagement in PrEP implementation.

[1]  M. Folayan,et al.  Ethics and HIV prevention research: An analysis of the early tenofovir PrEP trial in Nigeria. , 2018, Bioethics.

[2]  H. Rees,et al.  Designing PrEP and early HIV treatment interventions for implementation among female sex workers in South Africa: developing and learning from a formative research process , 2018, BMJ Open.

[3]  H. Rees,et al.  HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project , 2017, PLoS medicine.

[4]  J. Baeten,et al.  Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence , 2017, Journal of the International AIDS Society.

[5]  J. Baeten,et al.  Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa. , 2017, Gates open research.

[6]  S. Moses,et al.  Prioritizing Risk in Preparation for a Demonstration Project: A Mixed Methods Feasibility Study of Oral Pre-Exposure Prophylaxis (PREP) among Female Sex Workers in South India , 2016, PloS one.

[7]  J. Baeten,et al.  Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1–Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda , 2016, PLoS medicine.

[8]  R. Lorway,et al.  ‘No one was there to care for us’: Ashodaya Samithi's community-led care and support for people living with HIV in Mysore, India , 2016, Global public health.

[9]  C. Wachihi,et al.  “How I Wish This Thing Was Initiated 100 Years Ago!” Willingness to Take Daily Oral Pre-Exposure Prophylaxis among Men Who Have Sex with Men in Kenya , 2016, PloS one.

[10]  J. Baeten,et al.  I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation. , 2016, AIDS patient care and STDs.

[11]  Sheena McCormack,et al.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial , 2016, The Lancet.

[12]  Peter Vickerman,et al.  Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria , 2015, AIDS.

[13]  M. Folayan,et al.  Saying ‘No’ to PrEP research in Malawi: what constitutes ‘failure’ in offshored HIV prevention research? , 2015, Anthropology & medicine.

[14]  J. Banderas,et al.  A Peer-Led HIV Medication Adherence Intervention Targeting Adults Linked to Medical Care but without a Suppressed Viral Load , 2015, Journal of the International Association of Providers of AIDS Care.

[15]  J. Baeten,et al.  Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm. , 2015, AIDS.

[16]  K. Mayer,et al.  The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV prevention , 2015, Journal of the International AIDS Society.

[17]  J. Mcnicholl,et al.  The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs , 2015, AIDS.

[18]  M. Folayan,et al.  “Why should I take drugs for your infection?”: outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria , 2015, BMC Public Health.

[19]  J. Baeten,et al.  Successful Discontinuation of the Placebo Arm and Provision of an Effective HIV Prevention Product After a Positive Interim Efficacy Result: The Partners PrEP Study Experience , 2014, Journal of acquired immune deficiency syndromes.

[20]  M. Folayan,et al.  The use of antiretroviral therapy for the prevention of new HIV infection in populations at high risk for HIV sero-conversion in Nigeria. , 2014, African journal of reproductive health.

[21]  J. Baeten,et al.  Pre-exposure prophylaxis (PrEP) for HIV prevention , 2012 .

[22]  C. Hendrix,et al.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial , 2013, The Lancet.

[23]  John T Brooks,et al.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. , 2012, The New England journal of medicine.

[24]  James D. Campbell,et al.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. , 2012, The New England journal of medicine.

[25]  J. O’Neil,et al.  Exploring the Role of Community-Based Peer Support in Improving Access to Care and Antiretroviral Treatment for Sex Workers in Mysore, India , 2012 .

[26]  B. Haire.  Because we can: clashes of perspective over researcher obligation in the failed PrEP trials. , 2011, Developing world bioethics.

[27]  J. Simoni,et al.  Are Peer Interventions for HIV Efficacious? A Systematic Review , 2011, AIDS and Behavior.

[28]  David V Glidden,et al.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.

[29]  Clinical disciplines.  Pre-Exposure Prophylaxis , 2010 .

[30]  E. Bass,et al.  P15-21. Investigating the utility and relevance of the good participatory practice guidelines for biomedical HIV prevention trials , 2009, Retrovirology.

[31]  S. Ssali,et al.  Voluntary HIV counselling and testing among men in rural western Uganda: Implications for HIV prevention , 2008, BMC public health.

[32]  B. Stray-Pedersen,et al.  Low male partner participation in antenatal HIV counselling and testing in northern Tanzania: implications for preventive programs , 2008, AIDS care.

[33]  J. Orne‐Gliemann,et al.  Couple-centred testing and counselling for HIV serodiscordant heterosexual couples in sub-Saharan Africa , 2008, Reproductive health matters.